Patents by Inventor Maghsoud M. Dariani

Maghsoud M. Dariani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating attention deficit disorders with d-threo methylphenidate
    Patent number: 5908850
    Abstract: Methods for treating Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, AIDS Dementia Complex and cognitive decline in HIV-AIDS while minimizing drug hypersensitivity, toxicity, side effects, euphoric effect, and drug abuse potential by administration of d-threo-methylphenidate or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: April 2, 1997
    Date of Patent: June 1, 1999
    Assignee: Celgene Corporation
    Inventors: Andrew L. Zeitlin, Maghsoud M. Dariani, David I. Stirling
  • Delivery of multiple doses of medications
    Patent number: 5837284
    Abstract: Dosage forms for oral administration of a methylphenidate drug are provided. The dosage forms provide a substantially immediate dose of methylphenidate upon ingestion, followed by one or more additional doses at predetermined times. By providing such a drug release profile, the dosage forms eliminate the need for a patient to carry an additional dose for ingestion during the day. The dosage forms and methods provided are useful in administering methylphenidate and pharmaceutically acceptable salts thereof, which generally require one or more doses throughout the day.
    Type: Grant
    Filed: July 14, 1997
    Date of Patent: November 17, 1998
    Inventors: Atul M. Mehta, Andrew L. Zeitlin, Maghsoud M. Dariani